Xiaomi's Revenue Hits CNY 78 Billion in Q3 2021As of Q3 2021, Xiaomi has invested in more than 360 companies, with a book value of CNY 59.1 billion.
Xiaomi releases its Q3 earnings report for the period ended September 30, 2021, on November 23.
- Internet service revenue was CNY 7.3 billion, a 27.1% year-on-year increase, with 73.6 gross margin
- IoT and consumer products business revenue was CNY 20.9 billion.
- Net profit was CNY 5.2 billion, a 25.4% year-on-year increase.
- Global shipments of smartphones were 43.9 million units, ranking third in the world, with a 13.5% market share.
- The number of users of devices (excluding smartphones, tablets and laptops) exceeds 8 million, with more than 400 million devices connecting to Xiaomi Group's AIoT platform.
- R&D investment was CNY 3.2 billion, a 39.5% year-on-year increase.
So far, the company has built the world's largest consumer IoT platform, connected to more than 100 million smart devices, and entered more than 100 countries and regions around the world.
Chinastocks
Interesting Sityation The stock is approaching a strong support zone. Enter only on confirmation. At the moment the Chinese stock market is quite volatile, in particular the Alibaba Corporation itself. But securities of some Chinese companies are showing good growth right now
❤️ If you find this helpful and want more FREE forecasts in TradingView
. . . . . Please show your support back,
. . . . . . . . Hit the 👍 LIKE button,
. . . . . . . . . . . Drop some feedback below in the comment!
❤️ Your Support is very much 🙏 appreciated!❤️
💎 Want us to help you become a better Stock trader?
Now, It's your turn!
Be sure to leave a comment let us know how do you see this opportunity and forecast.
Is it time to invest in China?KWEB is a China technology based ETF.
Top 10 holdings by weight:
Tencent Holdings ~ 10.62%
Alibaba Group Holding ~ 10.32%
JD.com ~ 7.21%
Meituan ~ 6.99%
Pinduoduo Inc ~ 6.97%
NetEase Inc ~ 4.71%
Baidu Inc ~ 4.27%
Bilibili Inc ~ 3.83%
Trip.com Group ~ 3.82%
JD Health International ~ 3.32%
Fundamental Analysis
China’s stock market pullback this year has been in line with the average annual drawdown (approximately 30%); historically, this volatility has tended to produce double-digit annualized gains.
In terms of seasonality, over the past 20 years, October has been amongst the strongest months for the Chinese stock market.
Technical Analysis
The 50sma has been tested as resistance 3 times before. A breakout above the 50sma could signal a significant change in trend.
The RSI has shown a positive divergence, as the last three times, we tested the horizontal line (blue arrow), in each case RSI is showing higher lows.
XPeng G9 First LookThe company will hold the third-quarter conference call on November 23.
XPeng Motors will unveil the G9 SUV, the company's fourth model and the first after its brand refresh, on November 19 at 11:00 a.m. Beijing time.
Photos of the model have already appeared in the XPeng app before the model was officially unveiled.
As previously reported by yiche.com, the new model will be based on the same Edward platform as XPeng's flagship sedan P7, which supports a wheelbase range of 2,800-3,100mm.
The model is expected to be priced at around CNY 300,000 (USD 47,000), equipped with a more advanced autonomous driving system with LiDAR and support for XPILOT 4.0, the report said.
Early last month, a Weibo user said that the XPeng G9 could be officially launched in the fourth quarter of 2022.
The car's wheelbase is between 3050-3100mm, which is longer than the NIO ES8 and Li Auto's Li ONE. But the car may be less than 5 meters long, possibly slightly shorter than the latter two, according to the blogger.
Its price may lie in the range of CNY 300,000 to 400,000, between the P7, which starts at CNY 229,900, and the P7 Wing edition, which costs CNY 409,900, the blogger said.
This article was first published by Phate Zhang on CnEVPost, a website focusing on new energy vehicle news from China
For the full article with the images, please visit the original link.
NetEase Releases Third Quarter 2021 Unaudited Financial Results"As an innovation-driven content creator, we will continue to deliver thoughtful premium content and products to our users across each of our carefully cultivated disciplines," said the CEO and director of NetEase, William Ding.
Third Quarter 2021 Financial Highlights
- Net revenues were CNY 22.20 billion (USD 3.4 billion), an increase of 18.9% compared with the third quarter of 2020.
- Online game services net revenues were CNY 15.9 billion (USD 2.5 billion), an increase of 14.7% compared with the third quarter of 2020.
- Youdao net revenues were CNY 1.4 billion (USD 215.3 million), an increase of 54.8% compared with the third quarter of 2020.
- Innovative businesses and other net revenues reached CNY 4.9 billion (USD 761.1 million), an increase of 25.7% compared with the third quarter of 2020.
- Gross profit was CNY 11.8 billion (USD 1.8 billion), an increase of 19.5% compared with the third quarter of 2020.
Total operating expenses were CNY 8 billion (USD 1.2 billion), an increase of 14.5% compared with the third quarter of 2020.
- Net income attributable to the Company's shareholders was CNY 3.2 billion (USD 493.8 million). Non-GAAP net income attributable to the Company's shareholders was CNY 3.9 billion (USD 598.7 million).
Basic net income per share was USD 0.15 (USD 0.74 per ADS). Non-GAAP basic net income per share was USD 0.18 (USD 0.90 per ADS).
Third Quarter 2021 and Recent Operational Highlights
- Expanded games portfolio with new games in more diverse genres, including:
Naraka: Bladepoint, which broke the sales record of buy-to-play games by Chinese developers and led the Steam top-sellers chart, remaining in the top 5 for weeks following its global launch in August.
Harry Potter: Magic Awakened, which led China's iOS top grossing chart and top download chart following its launch in September.
- Exciting new titles in China such as Ace Racer, Infinite Lagrange and Nightmare Breaker.
Launched The Lord of the Rings: Rise to War in Europe, the Americas, Oceania and Southeast Asia.
Extended solid popularity of franchise titles including the Fantasy Westward Journey and Westward Journey Online series.
- Enriched dynamic game development pipeline with exciting advancements to upcoming games including The Showbiz: Dream Chaser, the console version of Naraka: Bladepoint, Diablo® Immortal™, as well as Ghost World Chronicle, and Harry Potter: Magic Awakened in international markets.
- Progressed Youdao's capabilities as an education technology provider, with steady advancements in STEAM courses, adult learning and smart learning hardware devices.
- Expanded NetEase Cloud Music's content ecosystem and product innovation capabilities to strengthen its highly-engaged music-enteric community, delivering a solid financial performance.
Revenue Reaches CNY 31.9 Bn as Baidu Announces Q3 2021"Baidu Core delivered another solid quarter, powered by our AI cloud revenue growing 73% year over year," said Rong Luo, CFO of Baidu. "With a diversified AI portfolio, including cloud services, smart transportation, smart devices, self-driving, smart EV and robotaxi, we are well-positioned for long-term growth."
Total revenues were CNY 31.9 billion, increasing 13% year-on-year.
Revenue from Baidu Core was CNY 24.7 billion, increasing 15% year-on-year; online marketing revenue was CNY 19.5 billion up 6% year-on-year and non-online marketing revenue was CNY 5.2 billion, up 76% year-on-year, driven by cloud and other AI-powered businesses.
Revenue from iQIYI was CNY 7.6 billion, increasing 6% year-on-year.
Cost of revenues was CNY 16.1 billion, increasing 26% year-on-year, primarily due to an increase in traffic acquisition costs, content costs and cost of goods sold related to new AI business.
Research and development expense was CNY 6.2 billion increasing 35% year-on-year, primarily related to personnel-related expenses.
Operating income was CNY 2.3 billion. Baidu Core operating income was CNY 3.7 billion and Baidu Core operating margin was 15%. Non-GAAP operating income was CNY 4.7 billion. Baidu Core non-GAAP operating income was CNY 5.8 billion and Baidu Core non-GAAP operating margin was 24%.
For the fourth quarter of 2021, Baidu expects revenues to be between CNY 31.0 billion and CNY 34.0 billion, representing a growth rate of 2% to 12% year-on-year, which assumes that Baidu Core revenue will grow between 5% and 16% year-on-year.
The COVID-19 situation in China is evolving and business visibility is limited. The above forecast reflects Baidu's current and preliminary view, which is subject to substantial uncertainties.
iQIYI Releases Q3 2021 Financial ResultsMr.Yu Gong, founder, director, and CEO of iQIYI, commented the Q3 performance was a 'softer than expected top-line performance'.
According to iQIYI's financial announcement for the third quarter of 2021:
- The total revenues achieved CNY 7.6 billion (USD 1.2 billion), showing a 6% increase from the same period last year.
- The operating loss was CNY 1.4 billion (USD 212.3 million) and the operating loss margin was 18%.
- The net loss attributable to iQIYI was CNY 1.7 billion (USD 268.4 million), compared to CNY 1.2 billion in the same period last year.
- As of September 30, 2021, the total number of paid subscribers of iQIYI was 103.6 million, or 103.0 million excluding individuals with trial memberships.
- Membership service business continued to be the largest business pillar with the revenue increased by 8% and accounting for 57% of the total revenue.
- Online advertising revenue decreased 10% year-over-year to CNY 1.7 billion primarily due to less premium content launched during the quarter and the challenging macroeconomic environment in China.
- The content distribution revenue achieved a 68% growth on year over year basis to CNY 627.1 billion, which was primarily driven by more content distributed to other platforms during the quarter.
- For the fourth quarter of 2021, iQIYI expects total net revenues to be between CNY 7.08 billion and CNY 7.53 billion, representing a 5% decrease to 1% increase year-over-year.
TAL Education Says Goodbye to K9 Academic AST ServicesTAL Education will explore quality-oriented education from multiple aspects.
On November 13, Zhang Bangxin, CEO of TAL (TAL:NYSE) issued an internal letter to all employees, indicating the new strategic direction for the future and the personnel adjustments made in accordance with the new direction.
According to the announcement, TAL plans to cease offering academic subjects to students from kindergarten through grade nine ('K9 Academic AST Services') in the mainland of China by the end of December 2021. Any course services users have signed up for would be guaranteed.
Zhang expressed that the company's business focus will be transferred from the subject training to quality-oriented training, aiming to cultivate the ability that will bring children lifelong benefit. Several trials have been made: on one hand, humanities and aesthetic education, scientific puzzles, programming and other subjects; on the other hand, it may actively explore music, sports, art and other categories.
The internal letter also mentioned that TAL will further increase investment in research and development for education technology, referring to science and technology to promote educational progress. Besides, TAL will promote overseas business with great patience, continuing to build overseas business models, brand awareness and operational capabilities in the next five to ten years or even more. Finally, TAL will continue to incubate new business, regarding it as a driving force for new organizational capacity. It said that the company would do more in digital content publishing, education hardware, hosting services and other aspects to be well-prepared for the future.
Zhang said that, although the main business has experienced huge changes, the unchanged initial motivation of education, the core management stability, the solid research and development accumulation and deep-rooted brand consciousness should help the company to locate its own position. It will continue to create value for customers, employees and the whole society.
BIMI time for a big breakoutBIMI had a run and left many gaps opened , now its time to fill out those gaps and fly in the sky .
This is a very risky trade
High risk / high reward.
Don’t enter if you can’t manage your trade
Trade Safe
The inflation is taking TBLT to the moonKeep it easy simple and safe
Enter at current price
TP1 0.72 (42% gain)
TP2 0.89 (74% gain)
TP3 1$+
SL 0.49 (4% loss )
Safe trade , trade safe ><><
NIO Setting Up + Upcoming Catalyst NIO DAYNIO, the electric vehicle company is setting up again after being on a serious downtrend since its surge in January. This surge was the result of lots of "hype" around the name, the rise of Tesla, and its upcoming NIO day which happened on January 9th, 2021. We saw a massive run up the month before, around 60%.
This year, NIO day is happening on Dec 18th, 2021. This should cause an influx of volume and talk about the name. Keep an eye on this one.
In order to confirm the Elliot waves, we still need to create the (E) section of the triangle. Once this is confirmed, I believe we can start rising. However, with NIO day approaching soon, there is the possibility of NIO ripping before the set up completes. I will be watching for any signs of a pullback and be entering calls and shares around the 38-40$ mark.
Definitely keep this one on watch because we know from previous bullish runs, that this thing can RUN. The upside potential is very high here.
Weibo Announces Q3 2021 Financial ReportThe leading social media in China, Weibo (NASDAQ: WB), released its unaudited financial results for the third quarter of 2021.
According to the Q3 performance report for 2021:
- The revenue totaled USD 607 million (CNY 3,882 million), increasing 30% year-on-year. As of September 30, 2021, the total cash, cash equivalents and short-term investments amounted to USD 2.71 billion (CNY 17.333 billion).
- The operating profit was USD 213 million (CNY 1,477 million), showing an upward trend of 32%, while the net profit was USD 182 million (CNY 1,164 million), growing 438% from the same period last year.
- The advertising and marketing revenue increased by 29% to USD 538 million (CNY 3,441 million), which was mainly due to stronger demand for advertising from key industries.
- Revenue from value-added services was USD 69.8 million (CNY 446 million yuan), up 42% year-on-year.
- The revenue cost was USD 394 million (CNY 2.520 billion), which was mainly related to increased staff-related costs and marketing expenses. Specifically, revenue costs, marketing costs, product development and administrative expenses were USD 103 million (CNY 659 million), USD 141 million (CNY 902 million), USD 119 million (CNY 761 million) and USD 31.75 million (CNY 238 million), respectively.
- As of September 2021, Weibo has 573 million monthly active users, and 94% of them are mobile users. In September 2021, the average daily active number of Weibo users reached 248 million. Affected by events such as the Olympics, its user base and traffic re-peaked in July and August after the outbreak since March 2020, reaching 302 million once.
Tencent's Profit Down 2% YoY for the First Time in 10 YearsThe drop was a result of regulatory crackdowns on media and restrictions on teenagers' gaming time.
Despite enhancing its parental control policy and constrained gaming time for teenagers (from 6.4% in Q3 2020 to 0.7% in Q3 2021), Tencent saw its domestic gaming service revenue increase by 5% and 20% for the overseas markets. However, Tencent's top moneymaker – mobile gaming – has seen its growth slow down for three consecutive quarters.
A series of media crackdowns in China has been influential on Tencent's advertising income. The YoY revenue grew only 5% due to the political impact on industries, such as education and insurance. In addition to the latest regulatory change, media advertising revenue primarily from the Tencent news app has dropped 4%.
Meanwhile, Tencent's free cash flow decreased by 14%.
TSMC To Produce Chips In Japan By 2024 In Deal With SonyThe deal worth USD 7 bn establishes joint venture company Japan Advanced Semiconductor Manufacturing.
TSMC's board of directors officially approved plans to build a chip factory in Kumamoto Prefecture, its first-ever Japanese plant. Sony is set to invest USD 500 million and will hold no more than a 20% stake in the joint company, according to a statement released on Tuesday. The project will be Japan’s largest financially supported endeavor for a foreign-controlled company with billions of Japanese Yen in subsidies. It will create 1,500 high-tech professional jobs in Japan with the construction of the chip plant scheduled to begin in 2022 and production slated to begin in 2024. TSMC already has a plant in Nanjing and is currently constructing a plant in Arizona in the U.S. with considerations to build a new chip facility in Germany.
The semiconductor industry has been a top priority for many nations grappling with recent supply chain shortages. Japan’s response to the crunch is a framework for subsidies that allows companies to build chip factories in the nation. The conditionality is that firms must respond to requests for increased production and prioritize supply to domestic companies should supplies of semiconductors become tight. Sony specifically is TSMC’s biggest client in Japan making the deal quite worthwhile for both ends. The plant will produce state-of-the-art 7-nanometer chips as well as less advanced but versatile 22- to 28-nanometer chips.
TSMC was founded in February 1987 by Zhang Zhongmou and is headquartered in Taiwan. It is a professional integrated circuit manufacturing server with the world's most advanced semiconductor technology.
NIO Q3 Earnings: What to ExpectWill the chip shortage affect Nio's Q3 results?
NIO will report unaudited third-quarter earnings on November 9 after the US market closes. So what can investors expect?
NIO has already released data showing that it delivered 24,439 vehicles in the third quarter, up 100 percent year-on-year and 11.6 percent from the second quarter. Of those, 5,418 ES8s, 11,271 ES6s, and 7,750 EC6s were delivered.
In a research note sent to investors on November 3, Deutsche Bank analyst Edison Yu's team said the delivery figures were largely in line with their latest forecast.
The team expects NIO's revenue to be CNY 9.33 billion in the third quarter, representing a 106.1 percent year-on-year increase and a 10.4 percent increase from the second quarter.
Yu's team expects NIO to report a gross margin of 17.0 percent in the third quarter and a vehicle margin of 18.6 percent. As a comparison, the company had a gross margin of 18.6 percent and a vehicle margin of 20.3 percent in the second quarter.
The team attributed their lower gross margin forecast to higher depreciation amortization.
Based on these figures, the team expects NIO to report a loss of CNY 0.82 per ADS in the third quarter. This compares with a figure of CNY 0.21 in the second quarter.
For the fourth-quarter outlook, Yu's team expects NIO's management to likely give guidance of 24,000-25,000 deliveries, considering that October's downtime resulted in only 3,667 deliveries for the month.
NIO's management has hinted that their order book has exceeded 10,000 units for several months in a row, so Yu's team expects NIO's deliveries in November and December to improve back to more than 10,000 units, and expects the company's guidance for fourth-quarter revenue may be in the CNY 9.5 billion-10 billion range.
NIO has previously said it aims to deliver three models next year, including its flagship sedan ET7, Yu's team noted, adding that they don't think NIO's management will do a complete refresh of its current models next year, as it believes they can remain competitive with the most competing German luxury models with minor updates.
Yu's team raised NIO's delivery forecast for next year from 150k to 160k and for 2023 from 245k to 285k.
Based on the latest delivery forecast, the team raised its price target on NIO by USD10 to USD70, still based on 8x 2023E EV/sales.
In a separate report sent to investors on November 4, Yu's team noted that NIO's stock has significantly underperformed its local peers over the past three months, but that could change soon.
The team believes that there are 2-3 potential catalysts that could help change the narrative on the stock next. Here's what they say:
1) 3Q21 earnings on 11/9: management will provide 4Q guidance that shows large step-up in volume recovery for Nov/Dec and while official consensus is likely too high, we believe buy-side expectations have already been reset.
2) November monthly deliveries: likely reported on 12/1 and should confirm robust demand for existing models despite greater competition.
3) NIO Day: will be held on 12/18 and we expect new models/technology to be unveiled that should boost both investor and consumer sentiment.
Notably, the team also cautioned that risks including further constraints from the supply chain, a sudden shift in EV investor sentiment and poor initial acceptance of new products could also invalidate these judgments.
NIO shares are up about 10 percent so far this month and up about 20 percent in the past month.
This article was first published by Phate Zhang on CnEVPost, a website focusing on new energy vehicle news from China.
Haier Founder Zhang Ruimin Steps Down as ChairmanZhang volunteered not to participate in the nomination of new directors. Zhou Yunjie was elected as the new chairman of the board and appointed as CEO. Liang Haishan was appointed as president.
During Zhang’s 37-year stint at Haier, the firm has grown from a Qingdao refrigerator factory with a sale revenue of only CNY 3.48 million but a deficit of CNY 1.47 million in 1984 to a global enterprise with a worldwide sale of more than CNY 300 billion and a pre-tax profit of more than CNY 40 billion in 2020.
According to the Qingdao-based firm, Zhang proposed a management model called Rendanheyi in 2005, which has 'become a trend during the era of Internet of things.'
As a legend in China's household appliance industry, Zhang, known as the 'godfather of Chinese management,' has been selected as one of the 50 most influential global management philosophers. In September 2021, Zhang and Eric Cornell, president of the European management development foundation, jointly signed the first international certification of innovative management, signifying that the Chinese enterprises have created the first international standard of management mode.
Consequently, Haier pioneered a new inheritance mechanism, enabling the company to keep evolving after transforming from its bureaucratic model into a self-driven enterprise.
Zhang was also among the 100 Chinese who were awarded the medals of reform pioneers during a grand gathering in December 2018 to mark the 40th anniversary of the country's reform and opening-up.
Lenovo Group's Net Profit Reached CNY 222.5 Bn in 2021 H1Hong Kong stocks of Lenovo Group fell by 0.35% to HKD 8.47/share, with a total market value of HKD 102 billion.
Lenovo Group has three major business groups, namely the intelligent equipment business group (IDG), the infrastructure solution business group (ISG), and the solution service business group (SSG).
The 2021 H1 financial reports for the Lenovo group are as follows:
- Revenue was USD 34.8 billion, a 24.87% year-on-year increase.
- Net income was USD 978 million, an 87% year-on-year increase.
- IDG's revenue reached USD 30 billion, an increase of 24.14% year-on-year, with USD 2.3 billion in net profit.
- ISG's revenue was USD 3.8 billion, an increase of 23.57% year-on-year, with USD 16.9 billion in net loss.
- SSG's revenue recorded USD 2.5 billion, an increase of 33.39% year-on-year, with USD 548 million in net profit.
The six months performance period ended September 20, 2021, are as follows:
- R&D expense was USD 948 million, accounting for 2.72% of revenue.
- SG&A expense was USD 3.3 billion, accounting for 9.44% of revenue.
The 2021 Q2 performance are as below:
- Revenue was USD 17.9 billion, a 23.07% year-on-year increase.
- Net income was USD 512 million, a 65.16% year-on-year increase.
TuSimple Releases 2021 Q3 Finanical ReportBank of America reiterated TuSimple at a 'buy' rating, with a target price of USD 60. The bank said TuSimple had plenty of liquidity despite still losing money in the third quarter.
According to TuSimple's financial announcement for the third quarter of 2021:
- The revenue was USD 1.80 million, increasing by 205.65% compared with the same period last year.
- The net loss was USD 115 million, increasing by 28.56% compared with the same period last year.
- The research and development expenditure increased by 40.75% to USD 84.51 million.
- The revenue cost was USD 3.49 million.
- The sales and marketing expenses were USD 910,000.
- The general and administrative expenses were USD 28.83 million.
- TuSimple holds USD 1,41 million in cash and cash equivalents as of September, 30.
- At the end of the reporting period, TuSimple's road mileage was 5.4 million miles (about 8.69 million kilometers), showing an upward trend of 17% compared with last month. Among them, the fully automated truck bookings totaled 6,875, 100 more than that in the second quarter; and map mapping miles totaled 9,900 miles, growing 16% from last quarter.
- TuSimple expects the full-year revenue would be USD 5 million to USD 7 million, with USD 200 million to USD 220 million investments in research and development.
NIO: Added Over 10k Orders in Oct, No Chip Shortage for OctNIO said in an announcement on its website yesterday that it delivered 3,667 vehicles in October, including 218 ES8s, 2,528 ES6s and 921 EC6s. That delivery volume fell 27 percent year-on-year and was 65.5 percent lower than in September.
After a short explanation of the dip in October deliveries on the NIO App yesterday, NIO co-founder and president Qin Lihong gave more details in an interview.
NIO's factory in Hefei ran at full capacity for only 10 days in October, so deliveries were low, but sales in October were excellent and reached a record high, local auto media Chedongxi said, citing an interview with Qin today.
Qin said he could not disclose the number of new orders, but said "it's definitely over 10,000, and we've been over 10,000 for several months in a row."
Chedongxi reports that their visits to NIO stores also confirm Qin's claims. A salesperson at an NIO store in Beijing's Wukesong said the store sold more than 100 units in October, a good month for the year.
"Because loan rates are going to be raised in November, 1,400 cars were sold across Beijing on October 31 alone," the salesperson said.
The company attributed this to lower production volumes due to production line restructuring and upgrades and preparations for new product introductions between September 28 and October 15, as well as certain supply chain fluctuations, but did not provide more details.
In the latest interview, Qin said NIO began a revamp of the JAC NIO manufacturing site in April and May this year to allow the ET7 to be produced and delivered in the first quarter of next year and to expand the plant's capacity.
The renovation was carried out in several phases so as not to affect the production of NIO's existing models, with the latest upgrade, which began at the end of September, being a very important phase, Qin said.
One of the tasks was the expansion of the body welding line, with more than 100 new robots alone. "After the equipment goes in and is commissioned, there's another week of complementing the line and capacity creep," Qin said.
As some car companies continue to blame the chip shortage for the decline in deliveries, Qin was also asked by Chedongxi if the decline in NIO deliveries was related to that, and Qin answered in the negative.
NIO's factory was open for just 10 days, and that little production wasn't enough to be affected by the chip shortage, he said.
Separately, according to Beijing News, Qin said NIO's current production pace is normal and orders in the clog will soon be cleared.
Consumers who order NIO vehicles now can get deliveries in six weeks at most, Qin said, adding that NIO deliveries will get back on track in November and December.
This article was first published by Phate Zhang on CnEVPost, a website focusing on new energy vehicle news from China.
Tencent Meeting Held 4 Bn Meetings in 2020, Hit 200 Mn UsersThe outbreak of COVID-19 in 2020 damaged many sectors. The videoconferencing market was among the winners.
Tencent Meeting (global version – VooV Meeting) took its second mover advantage and tightly followed its global counterpart – Zoom. Released in late December of 2019, Tencent Meeting, although coming out seven years later than Zoom, has now become the most used video conferencing app in China. According to Tencent's vice president Yuepeng Qiu, Tencent Meeting now attains (source in Chinese) 200 million users and held more than 4 billion meetings in 2020.
At the time Tencent Meeting was presented, no one could predict its future impact in China. From its bare-bone functionalities and dated UI in earlier versions (even today 26% of its user ratings are 1-star), we could speculate that this app initially wasn't the tech giant's top priority.
Resulting from its unexcepted success, Tencent Meeting now joins the Tencent enterprise services ecosystem. The following months will see more integration between Tencent Meeting and Enterprise WeChat.
BOE Reached CNY 20 billion in Net Profit as of Q3 2021In the first half of 2021, BOE continued to rank first in the world in terms of display shipments in the five application areas of smartphones, tablets, notebook computers, monitors, and TVs.
BOE released its Q3 earnings report for the period ended September 30, 2021, on October 28.
· Operating income was CNY 56 billion, a 46.8% year-on-year increase.
· Net profit was CNY 7.3 billion, a 441.1% year-on-year increase.
· Debt ratio was 13.88%.
· Gross margin reached 44.32%.
· Financial expenses were CNY 99 million.
The First three-quarter financial reports for the IoT firm are as below:
· Revenue was CNY 163.3 billion, a 72% year-on-year increase.
· Net profit was CNY 20 billion, a 708.4% year-on-year increase.
BOE issued the "Announcement on Provision for Asset Devaluation in the First Three Quarters of 2021." The company’s provision for inventory depreciation in the first three quarters of 2021 was 3.949 billion yuan, transferred back 1.24 billion yuan, and resold 792 million yuan. Inventory impairment losses in the first three quarters of 2021. The total profit is 1.918 billion yuan.
The company also released the investment project – "BOE Chengdu vehicle display project" with CNY 2.5 billion. The project strives to start production at the end of 2022, with an annual output of approximately 14.4 million onboard display screens after reaching full capacity.
Midea Announces the First 3 Quarters' Financial Results for 2021For the first three quarters, the domestic revenue increased by 24.7% and the overseas revenue increased by 15.51% compared with the same period last year.
According to Midea's financial results for the first three quarters of 2021:
- The revenue increased by 20.57% to CNY 261.342 billion, and net income attributable to the parent company was CNY 23.455 billion, with an increase of 6.53% year-on-year. Among them, Q3 revenue achieved CNY 87,532 million (up 12.66% YoY), while the net profit attributable was CNY 8,446 million (up 4.4% YoY).
- The company's domestic revenue increased by 17% in the third quarter of 2021, while overseas revenue increased by 6.4%. By the end of September, the company had added more than 36,000 overseas private label outlets for the whole year.
- The net cash flow from operating activities was CNY 27,897 million, with an increase by 11.52% compared to the same period last year, while its own capital amounted to CNY 128.1 billion (up 2.4% YoY).
- The company's research and development expenses amounted to CNY 8,765 million, showing a year-on-year increase of 30.51%.
- The online and offline shares of the domestic air-conditioning market are 34.8% and 35.8%, respectively.
- The online and offline shares of washing machines are 35.2% and 27.5%, respectively.
- The online and offline shares of refrigerators are 18.6% and 14.5%, respectively.
Founded in 1968, Midea is a global technology group covering five business sectors. It has about 200 subsidiaries with more than 60 overseas branches and 10 strategic business units, whose products and services benefit more than 200 countries and regions around the world for over 400 million users. It was listed on the Shenzhen Stock Exchange on September 18, 2013. As of the close of trading on October 29, 2021, the company's share price edged up by 0.95% to CNY 68.77, with a market capitalization of CNY 480.2 billion, ranking first in the domestic white home appliances industry.
Wuxi Apptec Embraces a More Health-Conscious ChinaAfter a booming year in 2018, Wuxi has yet to slow down. The following article analyzes the success of Wuxi and its shortcomings.
China has released a number of new policies to help make the biopharma industry more transparent and efficient.
By 2020, China had full coverage of medical service systems in rural and urban areas; 90% of residents in China can access the nearest medical point within 15 minutes.
Wuxi Apptec has achieved consecutive quarter-over-quarter revenue growth for 13 quarters since the first beginning of 2018 (other than the first quarter of 2020 due to Covid-19).
Wuxi PharmaTech, a contract research and manufacturing organization, was founded by Dr. Ge Li in 2000. The company changed its name to Wuxi Apptec after Wuxi acquired Apptec Laboratory Services Inc., a US-based medical device and biologics testing company. Wuxi was delisted from the NYSE after going private, with a valuation of USD 3.3 billion. The company has thrived under the leadership of Ge Li as Wuxi went from just 4 people in 2000 to over 28,000 employees in 2021. Ge Li claims that the company's main mission is to provide high-quality research services at a low cost.
Wuxi has been growing rapidly since its inception, but we expect more imminent growth as China rolls out new healthcare-related policies and people become more health-conscious. Although the thriving healthcare market will inevitably attract new entrants that may evolve into strong competitors, Wuxi Apptec is highly likely to withstand the competition.
Rising health awareness
While brands like GNC and The Vitamin Shoppe helped raise healthcare awareness in the west, China was lackluster in this department and put little emphasis on personal well-being. Over the past decade, however, China's healthcare industry grew exponentially as society's attitude towards healthcare took a massive turn. The rising disposable income has led to the paradigm shift from being reactive consumers to proactive consumers. 84% of 3,000 respondents in China, in a survey conducted by Ipsos, reported that they are consciously making health-oriented decisions now.
According to a report by McKinsey, the global wellness economy, accelerated by COVID-19, has an estimated market size of USD 1.5 trillion as of 2021 with 5% to 10% annual growth each year. China reported the highest share of wellness spending online out of the six countries, including Japan. Monosodium glutamate (MSG) is a controversial flavor-enhancing ingredient for its possible adverse effects after consuming more than 3 grams. Major MSG producer Henan Lotus is experiencing a steady decrease in sales as the Chinese population, once the largest consumer of MSG, is becoming more health-aware. Bain and Kantar Worldpanel also reported that sales of chewing gums have also decreased by 14% in the last two years, chocolate sales decreased by 6%, and confectionaries decreased by 4%.
Favorable policies
President Xi announced the initiation of the Health China 2030 (HC 2030) plan in October 2016. The main goals are to prioritize healthcare on a national level, spur innovations in the healthcare industry, promote scientific development, and bring equal access to public health services to all parts of China, especially the country's rural areas. HC 2030 also aims to establish and enhance social policies and institutional systems regarding health, cultivate a healthy environment and intensively promote the advancement of the healthcare industry. Companies in the healthcare industry have seen something of a boost in their revenue as the healthcare trend continues. By 2020, China had extended medical service coverage so thoroughly that 90% of residents could access the nearest medical point within 15 minutes. The medical cost growth was also curbed as 2020 marked the lowest proportion of residents' medical expenditure in 20 years, with 27.7%.
Government policies have favored the development of the healthcare industry in China, especially that of Contract Research Organizations (CROs) and Contract Development and Manufacturing Organizations (CDMOs). In 2015, China had a backlog of over 20,000 drug registrations pending review and approval. The National People's Congress (NPC) held a meeting to discuss the reformation of the drug registration system. As a result, China Food and Drug Administration (CFDA) regulators received more resources than in the past, and the government launched the Market Authorization Holder Program (MAH) to make it easier to bring new drugs to the market. Furthermore, the Review and Approve Process (RAP) was simplified and made more efficient. For example, high-quality generics for orphan conditions with robust bioequivalence data will be eligible for expedited review during the CFDA's regulatory process. As of July 2021, a rare disease database (Orphanet) has recognized over 6,000 diseases, propelling pharma companies to roll out more medicine that will undergo a newly implemented process. CROs and CDMOs benefit from these new policies as pharma companies look to increase their research output to develop and produce new drugs. The expedited RAP incentivizes companies to roll out new drugs to cope with the increasing number of orphan diseases recorded.
The unique advantage
Wuxi Apptec is a "fully integrated contract research development and manufacturing organization with the ability to provide one-stop services that offer its clients assistance in discovery, development and manufacturing service demands." The wide variety of services that Wuxi covers allows the company to embrace the soaring healthcare market in China. Wuxi Apptec expects to extend its impact further as the global new drug R&D outsourcing market snowballs. However, Wuxi must persist in its R&D investment to fare well against companies with more flexible cash flow and new entrants with newer technology.
With a boom in customer demand, China's pharmaceutical R&D and manufacturing service market is expected to maintain its current high-speed growth. Wuxi's unique competitive advantage comes from its cost-efficient services. As of 2021, Wuxi has over 28,000 employees, most of whom are chemists, making Wuxi possibly the biggest employer of chemists in the world. Since the company has cheaper labor costs than the industry average, Wuxi can produce almost the same amount of research output for a fraction of the price (around 25% to 40% less than western companies' services).
Additionally, policies such as the MAH, expedited reviews, and HC 2030 have encouraged pharmaceutical innovations in China. Wuxi can capture the rising demand from Chinese pharma companies with its rather high R&D efficiency. Although Wuxi may not have the financial strength of some significant pharma companies with in-house R&D departments, the company will retain its leading position as one of the most profitable R&D and manufacturing businesses in China.
Financial metrics
According to Wuxi's interim report this year, the company realized CNY 10.54 billion total revenue, a year-over-year growth of 45.70%. CNY 2.50 billion came from China, which represents year-over-year growth of 48%. This data showcases the company's ability to capture the rising healthcare tides and demands for research and innovations. 48% growth also marks the largest increase compared to the company's revenue growth in the US and Europe. Wuxi also has a 100% retention rate of its top 10 customers from 2015 to the interim of 2021. As of June 30, 2021, the company's new clients have contributed CNY 849 million in revenue. Frost & Sullivan published a market research report in June 2021, which ranked Wuxi Apptec first by market share in the China-based drug discovery CRO market, pre-clinical and clinical CRO market, and small molecule CDMO market.
Bottom line
The combined forces of new policies and rising healthcare awareness have put Wuxi Apptec in a prime position to consolidate its leadership in China. The company should remain profitable as long as it maintains below industry average labor cost, heavy investment in its R&D department and reasonable M&A strategies to help expand and improve Wuxi's services and operations. Given the recent regulatory crackdown on Chinese tech companies, Wuxi should tread carefully in its effort to capture a more significant share in the Chinese market.
China's rapid growth in the healthcare industry bodes well for the nation, but what does it mean for its people? While the government poured resources into promoting innovations and development in the medical field, the affordability issue gained little attention. Although China has over 90% of residents with basic health insurance plans, it still poses a hefty paycheck for the average worker. Despite the rising wave of healthy living, China has to do more to provide sustainable healthcare.
For the full article with the charts, please visit the original link.